​

Beam Therapeutics (BEAM) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Beam Therapeutics Revenue Highlights

00

Beam Therapeutics Revenue by Period

Beam Therapeutics Revenue by Year

DateRevenueChange
2025-12-31--100.00%
2024-12-31$63.52M-83.18%
2023-12-31$377.71M520.01%
2022-12-31$60.92M17.51%
2021-12-31$51.84M215916.67%
2020-12-31$24.00K33.33%
2019-12-31$18.00K100.00%
2018-12-31-100.00%
2017-12-31--

Beam Therapeutics generated - in revenue during NA 2025, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Beam Therapeutics Revenue by Quarter

DateRevenueChange
2026-06-30--100.00%
2026-03-31$31.74M-72.19%
2025-12-31$114.11M1076.62%
2025-09-30$9.70M14.55%
2025-06-30$8.47M13.33%
2025-03-31$7.47M-75.16%
2024-12-31$30.07M110.72%
2024-09-30$14.27M21.21%
2024-06-30$11.77M58.87%
2024-03-31$7.41M-97.66%
2023-12-31$316.19M1739.07%
2023-09-30$17.19M-14.53%
2023-06-30$20.12M-16.90%
2023-03-31$24.21M20.82%
2022-12-31$20.04M26.82%
2022-09-30$15.80M-5.12%
2022-06-30$16.65M97.49%
2022-03-31$8.43M-83.49%
2021-12-31$51.07M6593.18%
2021-09-30$763.00K12616.67%
2021-06-30$6.00K-
2021-03-31$6.00K-
2020-12-31$6.00K-
2020-09-30$6.00K-
2020-06-30$6.00K-
2020-03-31$6.00K-
2019-12-31$6.00K-
2019-09-30$6.00K-
2019-06-30$6.00K100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31--

Beam Therapeutics generated - in revenue during Q2 2026, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Beam Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
DTILPrecision BioSciences$34.26M-
FATEFate Therapeutics$6.65M$2.08M
CRSPCRISPR Therapeutics$3.51M$10.18M
CLLSCellectis$755.00K$4.53M
NTLAIntellia Therapeutics-$7.66M
EDITEditas Medicine--
ALLOAllogene Therapeutics--
CRBUCaribou Biosciences--
BEAMBeam Therapeutics--

BEAM Revenue FAQ

What is Beam Therapeutics’s yearly revenue?

Beam Therapeutics's yearly revenue for 2025 was $0, representing a decrease of -100.00% compared to 2024. The company's yearly revenue for 2024 was $63.52M, representing a decrease of -83.18% compared to 2023. BEAM's yearly revenue for 2023 was $377.71M, representing an increase of 520.01% compared to 2022.

What is Beam Therapeutics’s quarterly revenue?

Beam Therapeutics's quarterly revenue for Q2 2026 was $0, a -100.00% decrease from the previous quarter (Q1 2026), and a -100.00% decrease year-over-year (Q2 2025). The company's quarterly revenue for Q1 2026 was $31.74M, a -72.19% decrease from the previous quarter (Q4 2025), and a 324.87% increase year-over-year (Q1 2025). BEAM's quarterly revenue for Q4 2025 was $114.11M, a 1076.62% increase from the previous quarter (Q3 2025), and a 279.52% increase year-over-year (Q4 2024).

What is Beam Therapeutics’s revenue growth rate?

Beam Therapeutics's revenue growth rate for the last 3 years (2023-2025) was -100.00%, and for the last 5 years (2021-2025) was -100.00%.